Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2013
11/05/2013US8574863 Alkaline phosphatase for treating an inflammatory disease of the gastro-intestinal tract
11/05/2013US8574857 Method and means for treatment of osteoarthritis
11/05/2013US8574847 Use of blocker oligonucleotides in selective amplification of target sequences
11/05/2013US8574846 Recombinase polymerase amplification
11/05/2013US8574845 Method for identifying an increased susceptibility to ulcerative colitis
11/05/2013US8574844 Quantitative real-time assay for Noroviruses and Enteroviruses with built in quality control standard
11/05/2013US8574843 Genetic methods for speciating Campylobacter
11/05/2013US8574842 Direct molecular diagnosis of fetal aneuploidy
11/05/2013US8574841 Compositions, reaction mixtures and methods for detecting nucleic acids from type A1 and/or type C1 human papillomavirus
11/05/2013US8574840 Rotation-dependent transcriptional sequencing systems and methods of using
11/05/2013US8574839 Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
11/05/2013US8574838 Methods and kits for miRNA isolation and quantitation
11/05/2013US8574837 System for screening agonists/antagonists of cellular signaling pathways
11/05/2013US8574836 Method and apparatus for chromosome profiling
11/05/2013US8574835 Scaffolded nucleic acid polymer particles and methods of making and using
11/05/2013US8574834 Method for predicting the response to a therapy
11/05/2013US8574833 Methods and compositions for amplifying a detectable signal
11/05/2013US8574832 Methods for preparing sequencing libraries
11/05/2013US8574831 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
11/05/2013US8574830 Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses
11/05/2013US8574829 Methods of treating cancer with phenformin
11/05/2013US8574828 Controlled platelet activation to monitor therapy of ADP antagonists
11/05/2013US8574827 Modulators of angiogenesis and tumorigenesis
11/05/2013US8574623 Therapeutic agent for pulmonary fibrosis
11/05/2013US8574595 Virus purification using ultrafiltration
11/05/2013US8574592 Modified influenza virus for monitoring and improving vaccine efficiency
11/05/2013US8574590 Lipoparticles comprising proteins, methods of making, and using the same
11/05/2013US8574583 AAV capsid library and AAV capsid proteins
11/05/2013US8574581 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
11/05/2013US8574512 Laboratory device unit having a laboratory device and a remote control
11/05/2013US8574434 Integrated high throughput system for the analysis of biomolecules
11/05/2013US8574423 Biosensor, biosensor chip and biosensor device
11/05/2013CA2645663C Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/05/2013CA2593494C High throughput assay for cancer cell growth inhibition
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2507811C Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa) [af217798]
11/05/2013CA2473678C Automatically detecting cells having nuclear and cytoplasmic densitometric features associated with disease by optical imaging
11/05/2013CA2467936C Method of inhibiting gene expression
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2328403C Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
11/05/2013CA2316413C Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
11/01/2013CA2813873A1 Positive control concept
10/2013
10/31/2013WO2013163610A1 Identification and susceptibility of microorganisms by species and strain
10/31/2013WO2013163602A1 Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus
10/31/2013WO2013163568A2 Methods for evaluating lung cancer status
10/31/2013WO2013163455A2 A drug screening platform for rett syndrome
10/31/2013WO2013163451A1 Stain-free protein quantification and normalization
10/31/2013WO2013163428A1 Detection of ret fusions in cancer
10/31/2013WO2013163424A1 Apparatus with heterogeneous processing modules
10/31/2013WO2013163346A1 Synthetic promoter for modulating gene expression
10/31/2013WO2013163210A1 Method and system for detection of an organism
10/31/2013WO2013163207A1 Identification of 5-methyl-c in nucleic acid templates
10/31/2013WO2013163188A1 Compositions, methods and kits to detect herpes simplex virus nucleic acids
10/31/2013WO2013163152A1 Pre-anchor wash
10/31/2013WO2013162984A1 Methods for identifying subjects with an increased likelihood of responding to ccr1 antagonist
10/31/2013WO2013162948A2 Fluorous peptide microarray, detection process using a fluorous peptide microarray, and process of forming a fluorous peptide microarray
10/31/2013WO2013162776A1 Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression
10/31/2013WO2013162651A1 Biomarkers of immune dysfunction in response to chronic stress, methods of use and diagnostic kits
10/31/2013WO2013162286A1 Marker for detecting potency of adipose-derived stem cells, and use thereof
10/31/2013WO2013162276A1 Composition for detecting nucleic acid and method for detecting nucleic acid using same
10/31/2013WO2013162133A1 Method for detecting existence of heavy metals in mine soil using changes in expression of mtl-2 gene in caenorhabditis elegans
10/31/2013WO2013162109A1 Polymerase chain reaction primer and probe for detecting hepatitis b virus, and detection kit and method using same
10/31/2013WO2013162100A1 Biomarker composition for diagnosis of periodontal disease
10/31/2013WO2013162060A1 Method for predicting developmental toxicity while considering in vivo kinetics
10/31/2013WO2013162035A1 Modified amadoriase capable of acting on fructosyl hexapeptide
10/31/2013WO2013162026A1 Method for amplifying nucleic acid and method for detecting amplified nucleic acid
10/31/2013WO2013162021A1 Prophylactic or therapeutic agent for hepatic diseases
10/31/2013WO2013162012A1 Skin and hair color-controlling factor
10/31/2013WO2013162010A1 Method for determining read error in nucleotide sequence
10/31/2013WO2013161677A1 Method for assaying component to be assayed in specimen
10/31/2013WO2013161675A1 Method for stabilizing serum or plasma ascorbic acid
10/31/2013WO2013161614A1 Antigen detection method which uses lectin and comprises enzyme treatment step
10/31/2013WO2013161408A1 Method for inducing t cell differentiation, method for producing t cells, t cells, pharmaceutical composition, and screening method
10/31/2013WO2013160882A1 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method.
10/31/2013WO2013160836A1 Enhancing surface plasmon resonance imaging signal
10/31/2013WO2013160563A1 Method for competitive allele-specific cdna synthesis and differential amplification of the cdna products
10/31/2013WO2013160434A1 Detection method for mycobacterium avium ssp. paratuberculosis
10/31/2013WO2013160315A2 Genetic predictors of response to treatment with crhr1 antagonists
10/31/2013WO2013160204A1 Electrochemical competitive assay and use thereof
10/31/2013WO2013160176A1 Diagnostic mirna profiles in multiple sclerosis
10/31/2013WO2013159519A1 Dna decoding and sequencing method by real-time synthesis of two nucleotides
10/31/2013WO2013159293A1 Method, composition and kit for high throughput detection of genus plasmodium
10/31/2013WO2013159227A1 Bitter taste receptor constitutively active mutants
10/31/2013WO2013159200A1 Assays, methods and apparatus for assessing rna disruption
10/31/2013WO2013159189A1 Methods and apparatuses for evaluating water pollution
10/31/2013WO2013159145A1 A method of determining rna integrity
10/31/2013WO2013134496A3 Method, system and apparatus for automatic calibration of a needle valve device in a pressurized flow system
10/31/2013WO2013129655A3 Method for predicting proliferation of microbial count
10/31/2013WO2013126689A3 Compositions and methods to select for reduced grain moisture in maize
10/31/2013WO2013123030A3 Blood collection device for stabilizing cell -free plasma dna
10/31/2013WO2013121351A3 Oncogenic human cytomegalovirus
10/31/2013WO2013119193A3 Extracellular mitochondria-based screening and treatment
10/31/2013WO2013100810A3 Procedure for identifying the species and strain of lactobacillus using the genes of type ii toxin-antitoxin systems of the superfamilies relbe and mazef
10/31/2013WO2013040212A3 Unique transcriptional signatures in the blood of clinical responders
10/31/2013WO2012054530A3 Chemosensory receptor ligand-based therapies
10/31/2013WO2003027257A9 Methods of controlling gene expression and gene silencing
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2003020910A9 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL BETA-SUBUNIT, K+betaM8
10/31/2013WO2002077001A9 Novel receptors
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 3003